Eight strains of a previously undescribed coryneform bacterium had been isolated from human clinical material over a 5-year period. Colonies of the unknown coryneform bacterium had an unusual appearance as they were slightly yellowish and very mucoid. Biochemical and chemotaxonomic characterization revealed that the unknown coryneform bacterium belonged to the genus Corynebacterium. It could be readily differentiated from all previously described Corynebacterium species. Electron microscopy demonstrated the production of an extracellular substance causing connecting filaments between cells as a morphological correlate to the mucoid colonies. Comparative 16s rRNA gene sequence analysis revealed that the unknown coryneform bacterium represented a new subline within the genus Corynebacterium, for which the name Corynebacteriurn mucifaciens sp. nov. is proposed. The type strain is CCUG 36878 (= DSM 44265 = CIP 105129).
sections were contrasted with lead citrate and examined with a Philips model EM400 transmission electron microscope.
Chemotaxonomic investigations. The methods used for analyses of cellular fatty acids (gas-liquid chromatography [25] ), cell wall diamino acids (thin-layer chromatography [S] ), mycolic acids (thin-layer chromatography [S] ), the acyl type of the muramic acid (tube test [23] ), and the G + C content (high-performance liquid chromatography [7] ) have been described previously.
Antimicrobial susceptibility testing. MICs of 26 antimicrobial agents were determined by a microdilution method (Merlin Diagnostics, Bornheim-Hersel, Germany) as outlined previously (7). The results were interpreted by using National Committee for Clinical Laboratory Standards breakpoints (19) .
Determination of the 16s rRNA gene sequences and phylogenetic analyses. A large fragment of the 16s rRNA gene was amplified by PCR by using universal primers pA and pH* as previously described (15) . The PCR products were purified by using a Prep-A-Gene kit (Bio-Rad, Hercules, Calif.) and were sequenced by using a Tuq DyeDeoxy terminator cycle sequencing kit (Applied Biosystems, Foster City, Calif.) and a model 373A automatic sequencer (Applied Biosystems). Searches in the EMBWGenBank Data Library were performed with the program FASTA in order to establish the relatives of the clinical strains. Sequences of the close relatives were retrieved and aligned with the newly determined sequences by using the program PILEUP (5) . The rRNA alignment was corrected manually, and approximately 100 bases at the 5' end of the molecule were omitted from further analyses because of alignment uncertainties due to highly variable region Vl. Levels of sequence similarity were calculated and corrected for substitution rates by using Kimura's parameters. A phylogenetic tree was constructed by the neighbor-joining method (22) , and the stability of relationships was assessed by using the programs SEQBOOT, DNADIST, NEIGHBOR, and CONSENSE of the PHYLIP package (6) .
Nucleotide sequence accession number. The 16s rRNA gene sequence of strain DMMZ 227ST (= CCUG 3687gT = DSM 44265' = CIP 105125IT) has been deposited in the EMBL Data Library under accession no. Y11200.
RESULTS AND DISCUSSION
Six of the eight clinical strains were isolated from blood cultures ( Table 1 ). The remaining strains originated from a wound swab and joint fluid. All eight strains grew in pure culture from clinical specimens. The patients from whom the isolates were recovered were epidemiologically not linked.
Colonies of the strains were 1 to 1.5 mm in diameter after 24 h of incubation at 37°C in a 5% C02-enriched atmosphere. They were glistening, slightly yellowish, and very mucoid. A slimy consistency was also observed when colonies were subcultured for further testing, but colonies appeared to be less mucoid after 96 h of incubation. Initially, the mucoid colony appearance of the unknown bacterium somewhat resembled the appearance of Rhodococcus equi colonies (13) . However, we did not observe a rod-coccus cycle (as seen in R. equi strains [13] ) in the unknown bacteria when cells were grown on suitable media. Gram staining revealed typical diphtheroids which were VOL. 47, 1997 CORYWEBACTERIUM MUCIFACIENS SP. NOV. 953 occasionally club shaped, as seen only in true Corynebacterium spp. (11) . The eight strains examined were not partially acid fast. In order to visualize a possible mucus layer as the morphological correlate of the bacterial colony appearance, electron microscopy of ultrathin cross sections of the cells was performed. As seen in Fig. 1 , fine to broad electron-opaque filaments connected adjacent cells. A very similar pattern is observed in R. equi (12) . Otherwise, extracellular slime-producing Coynebacterium spp. are very rarely found (2) . The chemical structure of the filaments connecting the coryneform bacteria is not known at present, but it is not unlikely that the filaments are composed of polysaccharides which may represent a virulence factor, as demonstrated in R. equi (16) .
The following initial phenotypic screening characteristics of coryneform bacteria (24) were observed: cells were catalase positive, nonfermenting, nonmotile, nitrate reduction negative, and urea and esculin hydrolysis negative; acid was produced from glucose but not from maltose, mannitol, and xylose, and three of the eight strains produced acid from sucrose; the strains were nonlipophilic; and the CAMP reaction was negative. The API Coryne system gave the numerical codes 2100104 (n = 2), 2100105 (n = l), 6100104 (n = 3), and 6100105 (n = 2), which corresponded according to the system's database with identification of the isolates as the lipophilic taxa Corynebacterium jeikeium, Corynebacterium bovis, and CDC group G or the nonlipophilic, fermenting species Corynebacterium stn'atum (1). However, as revealed by the initial phenotypic screening reactions of the unknown coryneform bacteria, it was obvious that they did not belong to any of these taxa since they were nonlipophilic and nonfermenting. They could be readily distinguished from other nonfermenting corynebacteria (Table 2 ). Further testing of enzymatic reactions with the M I ZYM system revealed esterase, esterase-lipase, cystine arylamidase, and acid phosphatase activities but not valine arylamidase, a-glucosidase, and P-glucosidase activities, all of which are detected in R. equi strains (18) . In addition, the unknown coryneform bacteria produced acid from glycerol, fructose, and mannose, characteristics which are not observed in R. equi strains (17) .
In all eight clinical strains, C,,:, (42% 2 3% [mean 2 standard deviation]), C1s~lo9cis (40% 2 4%), and C18:, (11% k 3%) were the predominant cellular fatty acids (CFAs), which was compatible with assignment to the genus Coynebacterium (3, 25) . Significantly, in all of the strains tuberculostearic acid accounted for only 1 to 2% of the total CFAs. Tuberculostearic acid is very rarely found in nonlipophilic Corynebacterium spp. (3, 25) . In contrast, R. equi strains contain much larger amounts of tuberculostearic acid, up to 22% of their total CFAs (25) . Cell wall analysis revealed the presence of rnesodiaminopimelic acid as the diamino acid, as well as the presence of short-chain mycolic acids. Furthermore, the acyl type of the muramic acid of the eight strains studied was the acetyl type, as in Corynebacterium spp., and not the glycolyl type, as in Rhodococcus spp. (14). The G + C content was found to range from 63 to 65 mol%. All chemotaxonomic features, thus, were compatible only with assignment of the eight strains studied to the genus Corynebacterium (4).
The antimicrobial susceptibility patterns were similar for many of the isolates when the categories for susceptibility and resistance were applied. It was observed that the aminoglycosides amikacin (MIC at which 50% of the isolates were inhibited [MIC,,] , 0.25 pg/ml; MIC range, 50.125 to 0.5 pg/ml), gentamicin (MIC,,, 10.063 pg/ml; MIC range, 10.063 to 2 pg/ml), netilmicin (MIC,,, 50.063 pg/ml; MIC range, 50.063 pg/ml), and tobramycin (MIC,,, 0.125 pg/ml; MIC range, 10.063 to 0.25 pg/ml) exhibited good activity against the unknown Corynebacterium strains. In contrast, the tetracyclines doxycycline (MIC,,, 4 pg/ml; MIC range, 2 to 16 pg/ml), minocycline (MIC,,, 4 pg/ml; MIC range, 2 to 16 pg/ml), and tetracycline (MIC,,, 32 pg/ml; MIC range, 4 to 64 pg/ml) were only poorly active against most of the strains tested. Resistance to the macrolides azithromycin (MIC,,, >64 pg/ml; MIC range, 10.032 to >64 pg/ml), clarithromycin (MIC,,, 2 pg/ml; MIC range, 50.032 to 8 p,g/ml), and erythromycin (MIC,,, 264 p,g/ml; MIC range, 50.032 to >64 pg/ml) was observed in five of the eight strains, and the MIC of clarithromycin was consistently lower than the MICs of the other macrolides. Resistance to clindamycin (MIC,,, >32 pg/ml; MIC range, 0.25 to >32 pg/ml) was always combined with macrolide resistance, suggesting that an rRNA methylase was present, as has been observed in other coryneform bacteria (10) . The MICs of chloramphenicol (MIC,,, 8 pg/ml; MIC range, 4 to 128 pg/ml) were elevated for strains DMMZ 216 (MIC, 64 pg/ml) and DMMZ 418 (MIC, 128 pg/ml). Strains DMMZ 394 and DMMZ 2125 had slightly elevated penem MICs (e.g., the MIC of imipenem was 2 pg/ml), whereas for the other six strains the MICs of penems ranged from (0.032 to 0.06 pg/ml. Strain DMMZ 2125 was multiresistant since it was also resistant to rifampin (MIC, >32 pg/ml) and quinolones (e.g., the MIC for ciprofloxacin was 16 pg/ml) and exhibited elevated MICs with all p-lactams. Otherwise, the MICs of 6-lactams for the other seven strains were below the susceptible breakpoints; e.g., the MIC,, of cefazolin was 50.125 pg/ml (MIC range, 50.125 pg/ml), and the MIC,, of penicillin G was 0.25 pg/ml (MIC range, 0.125 to 1 pg/ml). Fusidic acid (MIC,,, 0.25 pg/ml; MIC range, 0.125 to 0.5 pg/ml), as well as the glycopeptides teicoplanin (MICSO, 0.5 pg/ml; MIC range, 0.25 to 0.5 pg/ml) and vancomycin (MIC,,, 0.5 pg/ml; MIC range, 0.5 pg/rnl), showed good activity against the eight isolates tested, whereas all eight isolates were resistant to aztreonam (MICSo, >64 pdml; MIC range, >64 pg/ml), cefetamet (MIC,,, >64 pg/ml; MIC range, >64 pdml), ceftibuten (MIC,,, >64 pg/ml; MIC range, >64 pg/ml), and fosfomycin (MICSO, >256 p&ml; MIC range, >256 p,g/ml).
In order to determine the phylogenetic position and the genealogical distinctiveness of the unknown Colynebacten'um strains, the genes encoding the 16s rRNA of strains DMMZ 300, DMMZ 394, DMMZ 1348, and DMMZ 2278' were amplified by PCR and subjected to sequence analysis. The almost complete 16s rRNA gene sequence (1,459 nucleotides) of strain DMMZ 2278T was determined. Comparative sequence analysis revealed that strain DMMZ 2278* was a member of the actinornycete high-G+C-content subphylum of gram-positive bacteria and displayed the highest sequence similarities (>92%) with species of the genus Colynebacterium ( Table 2) . Significantly lower levels of relatedness were found with other actinomycete and coryneform taxa (data not shown). A tree depicting the phylogenetic relationships of the unidentified bacterium within the genus Colynebacten'urn is shown in Fig. 2 . The new bacterium showed a close (approximately 1.5% 16s rRNA divergence) and statistically significant (bootstrap value, 90) phylogenetic affinity to Colynebacten'um afermentans (both subspecies), and Colynebacterium coyleae was the next nearest relative (Fig. 2) . Partial 16s rRNA sequence analyses (approximately 800 nucleotides, including variable regions V1 to V3) conducted with three other strains of the unidentified bacterium revealed 100% sequence similarity between isolates, thereby demonstrating the genealogical homogeneity of these organisms.
It is evident from both sequence divergence values and the -, negative; +, positive; V, variable. treeing analysis that the closest phylogenetic relatives of the unknown Corynebacterium strains are C. afermentans (approximately 98.5% 16s rRNA similarity) and C. coyleae (approximately 97.7% 16s rRNA similarity) ( Table 3 ). Although it is not possible to derive precise 16s rRNA sequence divergence values for delineating new species, the 1.5% 16s rRNA divergence between the unknown Corynebacterium sp. and its closest neighbors, together with the distinctive phenotype of the unknown Corynebacterium sp., clearly demonstrates that it represents a new species. It is important to note that within the genus Corynebacten'um many genomically distinct species, including Corynebacterium pseudodiphtheriticum and Corynebacterium propinquum (>99% 16s rRNA similarity), Corynebacterium diphtheriae, Coiynebactenum ulcerans, and Coiynebacterium pseudotuberculosis (>98% 16s rRNA similarity), and CDC coryneform group G bacteria and Coynebacterium accolens (>98% 16s rRNA similarity) (20, 21) , exhibit comparable or even higher levels of relatedness. Therefore, based on the results of phenotypic and molecular genetic studies, we propose that the unknown coryneform bacteria described above should be classified as members of a new species of the genus Corynebacterium, for which we propose the name Corynebacterium mucifaciens sp. nov. This species can be readily differentiated from other nonfermenting members of the genus Corynebacterium ( Table 2) .
Description of Corynebacterium mucifaciens sp. nov. Corynebacterium mucifaciens (mu.ci.fa'ci.ens. L. n. mucus, slime; L. part. adj. faciens, producing; L. part. adj. mucifiaciens, slime producing). The characteristics given below are based on the results of studies of eight strains. Cells are gram positive and nonmotile and do not form spores. Colonies are circular, convex, glistening, slightly yellowish, and mucoid. Colony diameters are about l to 1.5 mm after 24 h of incubation on sheep blood agar at 37°C. Catalase positive. Acid is produced from glycerol, glucose, fructose, and mannose but not from erythritol, arabinose, xylose, adonitol, p-methyl-xyloside, galactose, L-sorbose, rhamnose, dulcitol, inositol, mannitol, sorbitol, a-methyl-D-mannoside, a-methyl-D-glucoside, N-acetylglucosamine, amygdalin, arbutin, salicin, maltose, lactose, melibiose, trehalose, melezitose, D-raffinose, glycogen, p-gentiobiose, D-turanose, D-lyxose, D-tagatose, fucose, arabitol, gluconate, and 2-ketogluconate. Acid production from ribose and sucrose is variable. Nitrate is not reduced. Urea and esculin are not hydrolyzed. Not lipophilic. CAMP reaction negative. Pyrazinamidase, alkaline phosphatase, esterase, esterase-lipase, cystine arylamidase, and acid phosphatase are positive, whereas pyrrolidonyl arylamidase and phos-phoamidase are variable. Lipase, valine arylamidase, trypsin, chymotrypsin, a-galactosidase, P-galactosidase, P-glucuronidase, a-glucosidase, P-glucosidase, N-acetyl-P-glucosaminidase, a-mannosidase, and a-fucosidase activities are not detected.
The cell wall contains meso-diaminopimelic acid. Mycolic acids are present. The main straight-chain saturated fatty acids are palmitic and stearic acids; oleic acid is the predominant unsaturated fatty acid. The DNA base composition is 63 to 65 mol% G+C. Isolated from human clinical specimens. Type strain DSM 2278 has been deposited in the Culture Collection of the University of Goteborg, Goteborg, Sweden, as CCUG 36878, in the German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany, as DSM 44265, and in the Culture Collection of the Institut Pasteur, Paris, France, as CIP 105129. Strain CCUG 36878T has the characteristics described above for the species, except that it is positive for pyrrolidonyl arylamidase, phosphoamidase, ribose, and sucrose reactions. Its G + C content is 64 mol%.
